Taiyen Biotech CoTPE:1737 83 ROA % is 6.95% as of Dec. 2025, which is 44% above its 10-year median of 4.83. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,986 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 59.42% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Taiyen Biotech Co's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$572 Mil.
Taiyen Biotech Co's average Total Assets over the quarter that ended in Dec. 2025 was NT$8,232 Mil. Therefore, Taiyen Biotech Co's annualized ROA % for the quarter that ended in Dec. 2025 was 6.95%.
The historical rank and industry rank for Taiyen Biotech Co's ROA % or its related term are showing as below:
TPE:1737'
s ROA % Range Over the Past 10 Years
Min: 3.63 Med: 4.83 Max: 6.21
Current: 4.81
During the past 13 years, Taiyen Biotech Co's highest ROA % was 6.21%. The lowest was 3.63%. And the median was 4.83%.
TPE:1737's ROA % is ranked better than 59.42% of 1986
companies
in the Consumer Packaged Goods industry
Industry Median: 3.24
vs TPE:1737: 4.81
Taiyen Biotech Co (TPE:1737) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Taiyen Biotech Co ROA % Related Terms
Taiyen Biotech Co ROA % Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's ROA % distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Taiyen Biotech Co (TPE:1737) has a ROA % of 6.95% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Taiyen Biotech Co and its competitors. This is 44% above median its historical median of 4.83. Over the past decade, Taiyen Biotech Co's ROA % has ranged from 3.63 to 6.21. According to the industry distribution chart, Taiyen Biotech Co ranks #806 out of 1986 companies in the Consumer Packaged Goods industry, placing it in the top 40.6%.
Is Taiyen Biotech Co's ROA % too high?
Taiyen Biotech Co's current ROA % of 6.95% is 44% above median its 10-year median of 4.83. Over the past 10 years, this metric has ranged from a low of 3.63 to a high of 6.21. The Consumer Packaged Goods industry median ROA % is 3.24. Taiyen Biotech Co's value of 6.95% is 114.5% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #806 out of 1986 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's ROA % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #806 out of 1986 companies for ROA %. This puts Taiyen Biotech Co in the upper half of its industry. The industry median ROA % is 3.24. Taiyen Biotech Co's value of 6.95% is 114.5% above this benchmark. Historically, Taiyen Biotech Co's own ROA % has ranged from 3.63 to 6.21 over the past decade. While the company's 10-year median is 4.83 vs. the industry median of 3.24, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.24, based on 1,986 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current ROA % of 6.95% is 114.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current ROA % is 6.95%, which is 44% above median its own 10-year median of 4.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current ROA % is 6.95%, which is 44% above median its 10-year median of 4.83 and 114.5% above the Consumer Packaged Goods industry median of 3.24. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current ROA % is 6.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
ROA %: 6.95% (44% above median its 10-year median of 4.83)
GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 114.5% above the Consumer Packaged Goods median (#806 of 1986)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
